AMYLOID

Clinical trials for AMYLOID explained in plain language.

Never miss a new study

Get alerted when new AMYLOID trials appear

Sign up with your email to follow new studies for AMYLOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug trial targets dual brain proteins to slow lewy body dementia

Disease control Not yet recruiting

This study tests whether the drug donanemab can slow down worsening of thinking and daily living skills in people with early cognitive decline who also have signs of Lewy body dementia and Alzheimer's-related brain changes. About 350 participants will receive either donanemab or …

Matched conditions: AMYLOID

Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated May 17, 2026 03:42 UTC

AMYLOID

Get alerted when new AMYLOID trials appear

New drug trial targets dual brain proteins to slow lewy body dementia